期刊文献+

重症肌无力治疗研究的工具和方法 被引量:5

Tools and Methods to Evaluate the Therapeutic Effects of Myasthenia Gravis
原文传递
导出
摘要 重症肌无力(MG)病程长,且临床表现存在多样性,这些因素使对某一疗法的疗效客观评价的难度较大。规范化的临床评估对疗效判断具有重要意义。以严重性评价作为基础,有多种量表可用于MG疗效评价的各个方面。本文介绍这些量表并探讨相关的方法学问题。 The long course and various clinical manifestations of myasthenia gravis make it difficult to determine the therapeutic effects of a certain treatment. Standardized clinical evaluation is important to determine the therapeutic effects. Based on the evaluation of severity, various scales may be applied to many aspects of therapeutic effects in myasthenia gravis. The scales are summarized and related methodology is discussed in this report.
出处 《中国临床神经科学》 2007年第4期434-438,共5页 Chinese Journal of Clinical Neurosciences
关键词 重症肌无力 疗效 评估 myasthenia gravis therapeutic effects evaluation
  • 相关文献

参考文献25

  • 1Jaretzki A 3rd,Barohn RJ,Ernstoff RM,et al.Myasthenia gravis:recommendations for clinical research standards.Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America[J].Neurology,2000,55:16-23
  • 2Mertens HG,Balzereit F,Leipert M.The treatment of severe myasthenia gravis with immunosuppressive agents[J].Eur Neurol,1969,2:321-339
  • 3Szobor A.Myasthenia gravis:a quantitative evaluation system.Disability status scale(DSS)applied for myasthenia gravis[J].Eur Neurol,1 976,14:439-446
  • 4Oosterhuis HJ,Limburg PC,Hummel-Tappel E,et al.Anti-acetyl-choline receptor antibodies in myasthenia gravis.Part 2.Clinical and serological follow-up of individual patients[J].J Neurol Sci,1983,58:371-385
  • 5De Baets MH,Oosterhuis HJGH,eds.Myasthenia gravis[M].Boca Raton:CRC Press,1993:13-42
  • 6Mygland A,Aarli JA,Matre R,et al.Ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis[J].J Neurol Neurosurg Psychiatry,1994,57:843-846
  • 7Qureshi AI,Choudhry MA,Akbar MS,et al.Plasma exchange verSUS intravenous immunoglobulin treatment in myasthenic crisis[J].Neurology,1999,52:629-632
  • 8Besinger UA,Toyka KV,Homberg M,et al.Myasthenia gravis:long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity[J].Neurology,1983,33:1316-1321
  • 9Tindall RS,Phillips JT,Rollins JA,et alJ A clinical therapeutic trialof cyclosporine in myasthenia gravis[J].Ann N Y Acad Sci,1993,68l:539-551
  • 10Barohn RJ,McIntire D,Herbelin L,et al.Reliability testing of the quantitative myasthenia gravis score[J].Ann N Y Acad Sci,1998,841:769-772

二级参考文献17

  • 1[1]Drachman DB.N Engl J Med,1994,330:1797.
  • 2[2]Vincent A,Palace J,Hilton-Jones D.Lancet,2001,357:2122.
  • 3[3]Jaretzki A 3rd,Barohn RJ,Ernstoff RM,et al.Neurology,2000,55:16.
  • 4[4]Evoli A,Batocchi AP,Minisci C,et al.Neuromuscul Disord,2001,11:208.
  • 5[5]Barton JJ,Fouladvand M.Semin Neurol,2000,20:7.
  • 6[7]Wong V,Hawkins BR,Yu YL.Acta Neurol Scand,1992,86:68.
  • 7[9]Compston DA,Vincent A,Newsom-Davis J,et al.Brain,1980,103:579.
  • 8[10]Phillips LH 2nd.Ann N Y Acad Sci,2003,998:407.
  • 9[11]Muller-Hermelink HK,Marx A.Ann Med,1999,31:5.
  • 10[13]Willison HJ,Ang W,Gilhus NE,et al.Eur J Neurol,2000,7:625.

共引文献250

同被引文献64

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部